Optimizing Treatment Strategies for Adult Attention-Deficit Hyperactivity Disorder (ADHD)
Briefly

from National Institute of Mental Health (NIMH)5 months ago
The need for evidence-based treatments for adult ADHD, utilizing nonstimulant medications and psychosocial interventions, arises when stimulant monotherapy is inadequate or problematic.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/optimizing-treatment-strategies-for-adult-attention-deficit-hyperactivity-disorder-adhd
While ADHD treatment has historically focused on children, it’s now clear that many adults continue to experience significant symptoms that impair their daily functioning.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/optimizing-treatment-strategies-for-adult-attention-deficit-hyperactivity-disorder-adhd
Stimulants are traditionally the mainstay treatment for ADHD, yet they are not effective for everyone and come with risks of misuse and adverse effects.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/optimizing-treatment-strategies-for-adult-attention-deficit-hyperactivity-disorder-adhd
New FDA-approved nonstimulant medications and psychosocial interventions are necessary to provide comprehensive treatment for adults suffering from ADHD, especially when stimulants fail.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/optimizing-treatment-strategies-for-adult-attention-deficit-hyperactivity-disorder-adhd
Read at National Institute of Mental Health (NIMH)
#adult-adhd #nonstimulant-treatments #psychosocial-interventions #stimulant-medication-risks #fda-approved-medications
[
|
]